METHYLPREDNISOLONE VIATRIS 40 mg, powder for solution for injection (IM-IV) 20 bottles
Active ingredients: Methylprednisolone hemisuccinate, Methylprednisolone
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Powder for solution for injection20 bottlesintramusculaire;intraveineuse
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- METHYLPREDNISOLONE VIATRIS 40 mg, poudre pour solution injectable (IM-IV)
- Pharmaceutical form
- poudre pour solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 20 flacon(s) en verre de 40 mg
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 1 Jan 1997
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67672560CIP73554093CIP133400935540935Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MÉTHYLPREDNISOLONEpoudre | 40,00 mg · un flacon de lyophilisat | FT |
| HÉMISUCCINATE DE MÉTHYLPREDNISOLONEpoudre | 50,68 mg · un flacon de lyophilisat | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.